Press Releases
Allergan Presents Data at the 2018 American Academy of...
The meeting will be held at the San Diego Convention Center and the scheduled times (noted in local Pacific Time) for the Allergan presentations, titles...
Press Releases
Amgen sets up a FDA Advisory Committee Meeting To...
Amgen announced that the Oncologic Drugs Advisory Committee of the U.S. FDA will review data supporting the BLINCYTO® (blinatumomab) supplemental Biologics License Application (sBLA) for...
Press Releases
AbbVie presents New, Late Breaking Investigational Data at 2018...
AbbVie a global research and development-based biopharmaceutical company, today announced it will present new, late-breaking data across investigational medicines and HUMIRA® (adalimumab) at the 2018...
Press Releases
GSK’S Fluarix Tetra (Influenza Vaccine) for ages six months...
GSK announced the expanded indication for Fluarix Tetra (Quadrivalent Influenza Vaccine) has been approved in Europe to include adults and now children from six months...
Press Releases
GSK submits landmark IMPACT data to European Medicines Agencies...
GlaxoSmithKline plc and Innoviva, Inc. announced the submission of the landmark IMPACT data to the European Medicines Agency as part of a type II variation...
Press Releases
FDA Approves Symdeko
Vertex Pharmaceuticals Incorporated announced that the U.S. FDA approved Symdeko (tezacaftor/ivacaftor and ivacaftor) for treating the underlying cause of cystic fibrosis (CF) in people ages...
Press Releases
FDA Approves Erleada
The U.S. FDA approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.